EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Biological Evaluation of Resveratrol Methoxy Derivatives

Elizabeth Fragopoulou, Katerina Gkotsi, Filio Petsini iD, Katerina Gioti, Amalia D Kalampaliki iD, George Lambrinidis iD, Ioannis K Kostakis iD, Roxane Tenta iD

Molecules · 20.07.2023 · 28 (14) · 5547

DOI: 10.3390/molecules28145547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 20.07.2023. Verfasst von Elizabeth Fragopoulou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Dietetics, Harokopio University, 70 Eleftheriou Venizelou Avenue Kallithea, 17676 Athens, Greece. Hauptthemen laut MEDLINE: Platelet Aggregation, Blood Platelets. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Nutrition and Dietetics, Harokopio University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resveratrol, a naturally occurring stilbene, exhibits numerous beneficial health effects. Various studies have demonstrated its diverse biological actions, including anti-oxidant, anti-inflammatory, and anti-platelet properties, thereby supporting its potential for cardio protection, neuroprotection, and anti-cancer activity. However, a significant limitation of resveratrol is its weak bioavailability. To overcome this challenge, multiple research groups have investigated the synthesis of new resveratrol derivatives to enhance bioavailability and pharmacological activities. Nevertheless, there are limited data on the effects of resveratrol derivatives on platelet function. Therefore, the objective of this study was to synthesize resveratrol methoxy derivatives and evaluate their anti-platelet and anti-proliferative activity. Platelet-rich plasma (PRP) obtained from healthy volunteers was utilized to assess the derivatives’ ability to inhibit platelet aggregation induced by platelet activating factor (PAF), adenosine diphosphate (ADP), and thrombin receptor activating peptide (TRAP). Additionally, the derivatives’ anti-tumor activity was evaluated against the proliferation of PC-3 and HCT116 cells. The results revealed that some methoxy derivatives of resveratrol exhibited comparable or even superior anti-platelet activity compared to the original compound. The most potent derivative was the 4′-methoxy derivative, which demonstrated approximately 2.5 orders of magnitude higher anti-platelet activity against TRAP-induced platelet aggregation, indicating its potential as an anti-platelet agent. Concerning in silico studies, the 4′-methyl group of 4′-methoxy derivative is oriented similarly to the fluorophenyl–pyridyl group of Vorapaxar, buried in a hydrophobic cavity. In terms of their anti-tumor activity, 3-MRESV exhibited the highest potency in PC-3 cells, while 3,4′-DMRESV and TMRESV showed the greatest efficacy in HCT116 cells. In conclusion, methoxy derivatives of resveratrol possess similar or improved anti-platelet and anti-cancer effects, thereby holding potential as bioactive compounds in various pathological conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet AggregationBlood PlateletsHumansResveratrolPlatelet Aggregation InhibitorsPlatelet Function Tests

Stichwörter der Autor:innen

ADPcancermethoxyplatelet activating factorplateletsresveratrolthrombin

Substanzen

ResveratrolPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Nutrition and Dietetics, Harokopio University, 70 Eleftheriou Venizelou Avenue Kallithea, 17676 Athens, Greece.
  • Department of Pharmacy, Division of Pharmaceutical Chemistry, National and Kapodistrian University of Athens, 15771 Athens, Greece.

ORCID-Profile: Filio Petsini, Amalia D Kalampaliki, George Lambrinidis, Ioannis K Kostakis, Roxane Tenta

Förderung

  • Department of Nutrition and Dietetics, Harokopio University

Zitieren

APA

Fragopoulou, E., Gkotsi, K., Petsini, F., Gioti, K., Kalampaliki, A. D., Lambrinidis, G., Kostakis, I. K., & Tenta, R. (2023). Synthesis and Biological Evaluation of Resveratrol Methoxy Derivatives. Molecules, 28(14), 5547. https://doi.org/10.3390/molecules28145547

Vancouver

Fragopoulou E, Gkotsi K, Petsini F, Gioti K, Kalampaliki AD, Lambrinidis G, et al. Synthesis and Biological Evaluation of Resveratrol Methoxy Derivatives. Molecules. 2023;28(14):5547. doi:10.3390/molecules28145547

BibTeX
@article{Fragopoulou2023,
  author = {Fragopoulou, Elizabeth and Gkotsi, Katerina and Petsini, Filio and Gioti, Katerina and Kalampaliki, Amalia D and Lambrinidis, George and Kostakis, Ioannis K and Tenta, Roxane},
  title = {Synthesis and Biological Evaluation of Resveratrol Methoxy Derivatives},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {14},
  pages = {5547},
  doi = {10.3390/molecules28145547}
}
Kostenlos starten →